NCT05055193View on ClinicalTrials.gov

Outcome of Extremely Preterm Infants Who Received Systemic Postnatal Corticosteroid for Bronchopulmonary Dysplasia

CompletedOBSERVATIONAL
Enrollment

400

Participants

Timeline

Start Date

January 1, 2013

Primary Completion Date

January 1, 2013

Study Completion Date

December 31, 2018

Conditions
Bronchopulmonary Dysplasia
Interventions
DRUG

Evaluation at 24 months corrected age: respiratory outcome, Neurodevelopmental outcome, Growth outcome

Data concerning the 24 months corrected age outcomes were collected from the medical records of the ECL'AUR preterm infants follow-up network.

Trial Locations (1)

69004

Hospices Civil de Lyon, Lyon

All Listed Sponsors
lead

Hospices Civils de Lyon

OTHER

NCT05055193 - Outcome of Extremely Preterm Infants Who Received Systemic Postnatal Corticosteroid for Bronchopulmonary Dysplasia | Biotech Hunter | Biotech Hunter